Updated Jul 16, 2026
PYOTT DAVID E I has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.15M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | S — Open-market sale | 17 | $302.65 | $5K |
| 2026-06-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | S — Open-market sale | 495 | $300.72 | $149K |
| 2026-06-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | S — Open-market sale | 1.2K | $299.87 | $366K |
| 2026-06-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | S — Open-market sale | 1.2K | $298.91 | $351K |
| 2026-06-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | S — Open-market sale | 921 | $297.71 | $274K |
| 2026-06-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | M — Option exercise | 3.8K | $0.00 | |
| 2026-05-22 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | A — Grant or award | 671 | $0.00 | |
| 2026-04-28 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 1.4K | — | |
| 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | A — Grant or award | 775 | $0.00 |
PYOTT DAVID E I is a corporate insider — currently tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PYOTT DAVID E I profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.